Literature DB >> 1120140

Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes.

M D Greenspan, J I Germershausen, R Mackow.   

Abstract

The free acids of the plasma lipid-lowering agents, halofenate and clofibrate inhibited the incorporation of radioactive glucose and pyruvate into fatty acids of isolated adipocytes prepared from rat epididymal fat pads. The concentration which inhibited fatty acid synthesis was dependent on the bovine serum albumin concentration in the incubation. The 50 per cent inhibitory concentration of the free acid of halofenate in 1 per cent, 2 percent and 4 per cent albumin was 0.9 mM, 2.3 MM and 4.4 mM, respectively. The potency of clofibrate was also lowered by increasing the albumin concentration. These compounds inhibited the uptake of both [14C]glucose and [14C]pyruvate to the same degree as the incorporation of these substrates into fatty acids. However, the drugs either had no effect on , or stimulated the uptake of palmitate by the cells. Leucine accumulation by the adipocytes was unaffected by halofenate (free acid) and inhibited by clofibrate (free acid). A comparison of these agents with (minus)-hydroxycitrate, kynurenate and cerulenin (inhibitors of ATP-citrate lyase, acetyl CoA carboxylase and fatty acid synthetase, respectively) on the oxidation of pyruvate suggested that they inhibited pyruvate metabolism at or near the enzyme, pyruvate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120140     DOI: 10.1016/0005-2760(75)90005-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  p-Chlorophenoxyisobutyrate enhanced retention of homologous lipoproteins by human aortic smooth muscle cells.

Authors:  I Filipovic; E Buddecke
Journal:  Lipids       Date:  1977-12       Impact factor: 1.880

2.  Comparative effects of (--)-hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo.

Authors:  J Triscari; A C Sullivan
Journal:  Lipids       Date:  1977-04       Impact factor: 1.880

3.  Studies on the mechanism of action of halofenate.

Authors:  L R Mandel
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

4.  Hupolipidemic activity of (--)-hydroxycitrate.

Authors:  J G Hamilton; A C Sullivan; D Kritchevsky
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

5.  The NADPH consumption regulates the NADPH-producing pathways (pentose phosphate cycle and malic enzyme) in rat adipocytes.

Authors:  I Fabregat; E Revilla; A Machado
Journal:  Mol Cell Biochem       Date:  1987-03       Impact factor: 3.396

6.  Cross-Species Differential Plasma Protein Binding of MBX-102/JNJ39659100: A Novel PPAR-gamma Agonist.

Authors:  Holly J Clarke; Francine Gregoire; Fang Ma; Robert Martin; Spring Zhao; Brian E Lavan
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.